Baxter International Inc. (BAX - Free Report) delivered second-quarter 2019 adjusted earnings of 89 cents per share, which surpassed the Zacks Consensus Estimate of 81 cents by 9.9%. The bottom line also improved 15.6% from the year-ago quarter.
Revenues of $2.84 billion outpaced the Zacks Consensus Estimate of $2.79 billion by 1.9%. The top line fell 0.1% year over year on a reported basis but increased 4% on operational basis.
Geographical Details
Baxter reports operating results through three geographic segments — Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific).
In Americas, Baxter recorded revenues of $1.52 billion, down 0.3% on a year-over-year basis but up 1% at constant currency (cc).
In EMEA, revenues totaled $744 million, down 1.9% from the year-ago quarter but up 6% at cc.
In APAC, revenues of $576 million increased 3% from the prior-year quarter and 9% at cc.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Baxter International Inc. (BAX - Free Report) delivered second-quarter 2019 adjusted earnings of 89 cents per share, which surpassed the Zacks Consensus Estimate of 81 cents by 9.9%. The bottom line also improved 15.6% from the year-ago quarter.
Revenues of $2.84 billion outpaced the Zacks Consensus Estimate of $2.79 billion by 1.9%. The top line fell 0.1% year over year on a reported basis but increased 4% on operational basis.
Geographical Details
Baxter reports operating results through three geographic segments — Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific).
In Americas, Baxter recorded revenues of $1.52 billion, down 0.3% on a year-over-year basis but up 1% at constant currency (cc).
In EMEA, revenues totaled $744 million, down 1.9% from the year-ago quarter but up 6% at cc.
In APAC, revenues of $576 million increased 3% from the prior-year quarter and 9% at cc.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on BAX - FREE
Get the latest research report on XRAY - FREE
Get the latest research report on HOLX - FREE
Get the latest research report on TFX - FREE